Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

Abstract Background Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. Methods The goal of this ra...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-07-01
coleção:	Trials
Assuntos:	Nifurtimox Benznidazole Trypanosoma cruzi Chagas disese Randomized controlled trial
Acesso em linha:	http://link.springer.com/article/10.1186/s13063-019-3423-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!